CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Phase 1/2 Recruiting
152 enrolled
inMMyCAR
Phase 1 Recruiting
40 enrolled
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1/2 Recruiting
80 enrolled
Massage Impact on Sleep in Pediatric Oncology
Phase NA Recruiting
70 enrolled
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Recruiting
1,029 enrolled
Collection of Tissue Samples for Cancer Research
Recruiting
5,000 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
MK-3475-G21
Phase 1/2 Recruiting
20 enrolled
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Phase 2 Recruiting
496 enrolled
PROVIDENCE
Recruiting
132 enrolled
EPCOREâ„¢FL-2
Phase 3 Recruiting
1,095 enrolled
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Phase 1 Recruiting
50 enrolled
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Phase 2 Recruiting
14 enrolled
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Phase 2 Recruiting
32 enrolled
Sample Collection and Tracking for the Developmental Therapeutics Clinic
Recruiting
3,000 enrolled
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Phase 1 Recruiting
42 enrolled
TAPUR
Phase 2 Recruiting
4,200 enrolled
SURGE
Phase NA Recruiting
300 enrolled
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Phase NA Recruiting
40 enrolled
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
Phase NA Recruiting
188 enrolled
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Phase NA Recruiting
60 enrolled
Project: Every Child for Younger Patients With Cancer
Recruiting
75,000 enrolled
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Phase 1 Recruiting
33 enrolled
BOOSTER
Recruiting
300 enrolled
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Phase 2 Recruiting
75 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
Phase 1 Recruiting
150 enrolled
ReVenG
Phase 2 Recruiting
75 enrolled
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/2 Recruiting
90 enrolled
AYA STEPS
Phase NA Recruiting
260 enrolled
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
Phase 1 Recruiting
165 enrolled
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Phase 1 Recruiting
154 enrolled
MPGx-INDALL
Recruiting
556 enrolled
ON-5001
Phase 1 Recruiting
168 enrolled
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Phase NA Recruiting
60 enrolled
xDRIVE for Florida-based Cancer Patients
Phase NA Recruiting
210 enrolled
CAYA Cancer Retrospective Cohort Study
Recruiting
18,000 enrolled
VeRVe
Recruiting
500 enrolled
POSBIO-CRC
Phase NA Recruiting
164 enrolled
DAHLIA
Phase 1/2 Recruiting
85 enrolled
VIWA-1
Phase 2 Recruiting
80 enrolled
LIBERATE
Recruiting
2,500 enrolled
DETERMINE
Phase 2/3 Recruiting
825 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
Indocyanine Green (ICG) Guided Tumor Resection
Phase 1 Recruiting
230 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
PEDALL
Phase NA Recruiting
376 enrolled